Table II.

Correlation between the protein expression of Tat-interacting protein (TIP)30 and epidermal growth factor receptor (EGFR), and the clinicopathological features of patients with glioma.

Variable	n	TIP30			EGFR
		Positive	Negative	P-value	Positive	Negative	P-value
Tissue				0.03			0.04
Glioma	92	50	42		53	39
Normal brain	10	9	1		2	8
Gender				0.76			0.21
Male	40	21	19		26	14
Female	52	29	23		27	25
Age				0.14			0.33
>35 years	56	27	29		30	26
≤35 years	36	23	13		23	13
Histology				0.03			0.03
Astrocytomas	42	27	15		20	22
Oligodendrogliomas	25	15	10		13	12
Glioblastoma multiforme	25	8	17		20	5
Pathological grade				0.03			0.01
I–II	42	28	14		18	24
III–IV	50	22	28		35	15
Tumor size (cm)				0.02			0.01
≥5	47	20	27		33	14
<5	45	30	15		20	25